SLL-627 is a highly selective and potent κ opioid receptor (KOR) agonist with an unexpected nonreduction in locomotor activity
L Kong, X Shu, S Tang, R Ye, H Sun… - Journal of Medicinal …, 2022 - ACS Publications
Undue central nervous system (CNS) side effects including dysphoria and sedation remain
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …
SLL-627 Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity
L Kong, X Shu, S Tang, R Ye, H Sun… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Undue central nervous system (CNS) side effects including dysphoria and sedation remain
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …
SLL-627 Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor Activity.
L Kong, X Shu, S Tang, R Ye, H Sun… - Journal of Medicinal …, 2022 - europepmc.org
Undue central nervous system (CNS) side effects including dysphoria and sedation remain
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …
to be a challenge for the development of κ opioid receptor (KOR) agonists as effective and …